Related Articles
Elevated tumor mutation burden and immunogenic activity in patients with hormone receptor‑negative or human epidermal growth factor receptor 2‑positive breast cancer
Correlations between serum lipid and Ki‑67 levels in different breast cancer molecular subcategories
Cyclooxygenase‑2 expression in non‑metastatic triple‑negative breast cancer patients
No association between triple‑negative breast cancer and prognosis of patients receiving breast‑conserving treatment
Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients